KindlyMD(R) Announces Third Quarter 2024 Financial Results
KindlyMD(R) Announces Third Quarter 2024 Financial Results
"We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4% growth sequentially. This greatly improves the accessibility of our services, making them available to a broader patient base and allowing financial flexibility for our patients to visit more often," Tim Pickett, PA-C, KindlyMD Founder and CEO, stated. "Our strategic focus on expanding capacity and network has proven our model can achieve in-network status with the largest payers. We can use this status to help grow the number of lives we treat in Utah and beyond. We have also begun to develop enterprise-level data analytics and are excited to drive more personalized and effective care in the fight to improve health outcomes faster and at lower patient cost. We now also have the ability to aggregate and analyze disjointed data from many sources, uncovering drug usage trends, product effectiveness, patient risk factors, and opportunities to enhance therapies."Q3 Reimbursements from insurance payors totaled $106,567 an increase of 16.4% sequentially
保險支付方第三季度報銷總額爲106,567美元，按季增長16.4%
KindlyMD now provides more than 90% in-network insurance coverage in Utah
KindlyMD現在在猶他州提供超過90%的網絡內保險覆蓋
SALT LAKE CITY, UT / ACCESSWIRE / November 13, 2024 / ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services, today announced its financial results for the third quarter ended September 30, 2024.
猶他州鹽湖城/ ACCESSWIRE/ 2024年11月13日/ ("KindlyMD" 或"公司") (納斯達克:KDLY)，一個以患者爲先的醫療保健和醫療數據公司，正在重新定義以價值爲核心的護理和以患者爲中心的醫療服務，今天宣佈了截至2024年9月30日第三季度的財務業績。
"We are pleased with the progress made during the third quarter to expand our credentialing and increase insurance visits, resulting in a 16.4% growth sequentially. This greatly improves the accessibility of our services, making them available to a broader patient base and allowing financial flexibility for our patients to visit more often," Tim Pickett, PA-C, KindlyMD Founder and CEO, stated. "Our strategic focus on expanding capacity and network has proven our model can achieve in-network status with the largest payers. We can use this status to help grow the number of lives we treat in Utah and beyond. We have also begun to develop enterprise-level data analytics and are excited to drive more personalized and effective care in the fight to improve health outcomes faster and at lower patient cost. We now also have the ability to aggregate and analyze disjointed data from many sources, uncovering drug usage trends, product effectiveness, patient risk factors, and opportunities to enhance therapies."
"我們對第三季度擴大我們的資格和增加保險就診次數取得的進展感到滿意，導致按季度增長16.4%。這極大地提高了我們服務的可及性，使其面向更廣泛的患者群體，併爲我們的患者提供了更多訪問的財務靈活性，" Tim Pickett, PA-C, KindlyMD創始人兼首席執行官, 表示。"我們戰略上聚焦於擴大能力和網絡已經證明我們的模式可以與最大的支付方達成網絡內地位。我們可以利用這一地位幫助在猶他州和更遠的地方增加我們治療的人數。我們還開始開發企業級數據分析，並且對能夠以更加個性化和有效的方式推動改善健康結果的護理充滿期待，而且可以以更低的患者成本更快地實現健康結果。我們現在也有能力彙總和分析來自許多來源的不連貫數據，發現藥物使用趨勢、產品有效性、患者風險因素以及提高療法的機會。"
Operational Highlights:
經營亮點：
Achieved above 90% statewide insurance coverage in Utah with the addition of the largest health insurer in the United States, United Healthcare Insurance.
Introduced $500,000 share repurchase program to enhance shareholder value.
Recognized as one of the winners of the Healthcare AI Impact Award 2024.
Appointed Jeremy Joyal as Medical Director & Nancy Pratt as Behavioral Health Program Director.
通過與美國最大的健康保險公司美國聯合健康保險的合作，實現了猶他州90%以上的全州保險覆蓋。
推出50萬美元的股份回購計劃，以提升股東價值。
被認可爲2024年醫療保健人工智能影響獎的獲獎者之一。
任命Jeremy Joyal爲醫療主任，Nancy Pratt爲行爲健康項目主任。
Financial Highlights for the Quarterly Period Ended September 30, 2024
The Company earned $106,567 in reimbursements from insurance payers during the three months ended September 30, 2024, representing a 16.4% increase compared to the $91,553 earned during the three months ended June 30, 2024. The Company earned $232,892 in reimbursements from insurance payers during the nine months ended September 30, 2024, and $0 during the three and nine months ended September 30, 2023.
截至2024年9月30日季度結束的財務要點。
公司在2024年9月30日結束的三個月內從保險支付者處獲得106,567美元的報銷，較2024年6月30日結束的三個月內獲得的91,553美元增長了16.4%。公司在2024年9月30日結束的九個月內從保險支付者處獲得232,892美元的報銷，在2024年9月30日結束的三個月和九個月內沒有獲得任何報銷。
Revenues decreased by $221,401, or 25.5%, to $647,867 for the three months ended September 30, 2024, from $869,268 for the three months ended September 30, 2023. The decrease in revenues is primarily attributed to a decrease in cash-pay patient care services as KindlyMD continues to shift toward insurance billing with commercial and governmental payers including Medicare, Medicaid, Select Health, Blue Cross Blue Shield, Cigna, and other commercial payers compared to the prior period.
營業收入下降221,401美元，或25.5%，至2024年9月30日結束的三個月的647,867美元，而2023年9月30日結束的三個月爲869,268美元。營業收入下降主要歸因於現金支付患者護理服務的減少，因爲KindlyMD繼續向商業和政府支付者，包括醫療保險、醫療補助、Select Health、藍十字藍盾、Cigna和其他商業支付者轉向保險賬單與之前期間相比。
During the quarter, the Company generated revenue from service affiliate agreements for the first time. Service affiliate agreement earnings for the period were $22,432.
公司在本季度首次從服務聯盟協議中產生收入。該期間的服務聯盟協議收入爲22,432美元。
Operating expenses increased by $316,820, or 22.9%, to $1,697,685 for the three months ended September 30, 2024, from $1,380,865 for the three months ended September 30, 2023. The increase in operating expenses is primarily attributable to an increase in general and administrative expenses, salaries and wages, and cost of revenues.
營業費用增加了316,820美元，或22.9%，至2024年9月30日結束的三個月的1,697,685美元，而2023年9月30日結束的三個月爲1,380,865美元。營業費用增加主要歸因於一般和行政開支、工資、收入成本的增加。
Net loss was $1,014,147 for the three months ended September 30, 2024, compared to a net loss of $515,146 for the three months ended September 30, 2023. Net loss per share decreased by $0.06, or 54.5%, to $(0.17) for the three months ended September 30, 2024, compared to $(0.11) for the three months ended September 30, 2023. KindlyMD management strives to look for opportunities to optimize revenue by increasing sales, acquiring additional clinics, improving margins, and controlling ongoing operating expenses.
淨虧損爲2024年9月30日結束的三個月的1,014,147美元，而2023年9月30日結束的三個月爲淨虧損515,146美元。每股淨虧損減少了0.06美元，或54.5%，至2024年9月30日結束的三個月的-0.17美元，而2013年9月30日結束的三個月爲-0.11美元。KindlyMD管理層努力尋求機會通過增加銷售、收購額外診所、提高利潤率和控制持續營業費用來優化營業收入。
As of September 30, 2024, the company had cash and cash equivalents of $3,642,944 and total working capital of $3,215,466.
截至2024年9月30日，該公司的現金及現金等價物爲3,642,944美元，總營運資本爲3,215,466美元。
As of November 8, 2024, the Company had 5,977,476 common shares outstanding.
截至2024年11月8日，公司擁有5,977,476股普通股。
About KindlyMD
KindlyMD is a patient-first healthcare and healthcare data company redefining value-based care and patient-centered medical services. Kindly MD leverages data analysis to deliver evidence-based, personalized solutions in order to reduce opioid use, improve health outcomes faster, and provide algorithmic guidance on the use of alternative medicine in healthcare. We collect and analyze valuable data on alternative treatments as well as biopsychosocial factors to provide better health outcomes faster. This results in valuable data for patients, the company, and the company's investors as we aim to become a leading source of evidence-based assessment and treatment data in the fight for patients against the opioid epidemic and as we strive to be a leader in redefined value-based care.
關於KindlyMD
KindlyMD是一家以患者爲中心的醫療保健和醫療數據公司，重新定義價值爲本護理和以患者爲中心的醫療服務。Kindly MD利用數據分析提供基於證據的個性化解決方案，以減少阿片類藥物的使用，更快地提高健康結果，並在醫療保健中提供替代藥物使用的算法指導。我們收集並分析有關替代治療以及生物—心理—社會因素的寶貴數據，以更快地實現更好的健康結果。這將爲患者、公司和公司的投資者提供寶貴的數據，因爲我們致力成爲抗擊阿片類藥物危機的主要基於證據的評估和治療數據來源，並努力成爲重新定義的價值爲本護理領域的領軍者。
KindlyMD provides a patient-focused healthcare experience that integrates traditional medical evaluation and management with mental health integration and compliant alternative medicine education and inclusion. We focus on creating personalized care plans for each individual that get people back to work and life faster, reduce opioid use, and have high patient satisfaction.
KindlyMD提供以患者爲中心的醫療體驗，整合傳統醫學評估和管理與心理健康整合以及合規的替代醫學教育和包容。我們專注於爲每個個體創建個性化護理計劃，讓人們更快地重返工作和生活，減少阿片類藥物的使用，並獲得高滿意度。
Its specialty outpatient clinical services are reimbursed by Medicare, Medicaid, and commercial insurance contracts as well as offered on a fee-for-service basis. For more information, please visit .
其專科門診臨床服務通過醫療保險、醫療補助和商業保險合同以及按服務收費的方式獲得報銷。欲了解更多信息，請訪問。
Forward-Looking Statements
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
前瞻性聲明
本新聞稿包含基於當前預期並涉及美國1995年《私人證券訴訟改革法案》意義內的一些風險和不確定性的前瞻性聲明。此類前瞻性聲明可以通過使用諸如「應該」、「可能」、「打算」、「預期」、「相信」、「估計」、「項目」、「預測」、「期望」、「計劃」和「建議」等詞語來識別。這些前瞻性聲明不是對未來績效的保證，並且受到風險、不確定性和其他一些超出我們控制和難以預測的因素的影響，會導致實際結果與前瞻性聲明中表達或預測的有所不同。我們建議您仔細審查和考慮任何警示性聲明和其他披露，包括在KindlyMD股東會年度報告（截至2022年12月31日財政年度的Form 10-K表格）欄目下所做的聲明。KindlyMD股東會不承擔除法律規定外的任何更新前瞻性聲明的責任。出現在我們網站和社交媒體平台上的信息，包括但不限於Instagram和Facebook的信息，不是本新聞稿的一部分。
KINDLY MD, INC.
CONDENSED BALANCE SHEETS
KINDLY MD, INC.
簡明資產負債表
September 30, 2024 |
December 31, 2023 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ |
3,642,944 |
$ |
525,500 |
||||
Accounts receivable |
45,323 |
28,001 |
||||||
Inventories, net |
2,750 |
63,202 |
||||||
Prepaid expenses and other current assets |
250,316 |
225 |
||||||
Total Current Assets |
3,941,333 |
616,928 |
||||||
Property and equipment, net |
183,349 |
235,292 |
||||||
Operating lease right-of-use assets |
188,204 |
235,706 |
||||||
Security deposits |
11,276 |
11,276 |
||||||
TOTAL ASSETS |
$ |
4,324,162 |
$ |
1,099,202 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
||||||||
Current Liabilities |
||||||||
Accounts payable and accrued expenses |
$ |
431,516 |
$ |
329,810 |
||||
Customer deposits |
2,750 |
3,425 |
||||||
Current portion of operating lease liabilities |
100,982 |
94,696 |
||||||
Current portion of finance lease liabilities |
2,020 |
- |
||||||
Current portion of notes payable, net |
188,599 |
148,517 |
||||||
Derivative liability |
- |
238,000 |
||||||
Total Current Liabilities |
725,867 |
814,448 |
||||||
Operating lease liabilities, net of current portion |
106,114 |
164,295 |
||||||
Finance lease liabilities, net of current portion |
8,126 |
|||||||
Notes payable, net of current portion |
- |
228,871 |
||||||
TOTAL LIABILITIES |
840,107 |
1,207,614 |
||||||
Stockholders' Equity (Deficit) |
||||||||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; none issued and outstanding as of September 30, 2024 and December 31, 2023 |
- |
- |
||||||
Common stock, $0.001 par value, 100,000,000 shares authorized; 5,977,476 and 4,617,798 shares issued and outstanding as of September 30, 2024 and December 31, 2023, respectively |
5,977 |
4,618 |
||||||
Additional paid-in capital |
10,252,258 |
4,045,024 |
||||||
Accumulated deficit |
(6,774,180) | (4,158,054) | ||||||
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) |
3,484,055 |
(108,412) | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
4,324,162 |
$ |
1,099,202 |
||||
2024年9月30日 |
2023年12月31日 |
|||||||
(未經審計) |
||||||||
資產 |
||||||||
流動資產 |
||||||||
現金及現金等價物 |
$ |
3,642,944 |
$ |
525,500 |
||||
應收賬款 |
45,323 |
28,001 |
||||||
淨存貨 |
2,750 |
63,202 |
||||||
預付費用及其他流動資產 |
250,316 |
225 |
||||||
流動資產合計 |
3,941,333 |
616,928 |
||||||
物業和設備，淨值 |
183,349 |
235,292 |
||||||
經營租賃使用權資產 |
188,204 |
235,706 |
||||||
按金 |
11,276 |
11,276 |
||||||
資產總計 |
$ |
4,324,162 |
$ |
1,099,202 |
||||
負債和股東權益(赤字) |
||||||||
流動負債 |
||||||||
應付賬款和應計費用 |
$ |
431,516 |
$ |
329,810 |
||||
客戶存款 |
2,750 |
3,425 |
||||||
經營租賃負債流動部分 |
100,982 |
94,696 |
||||||
融資租賃負債的流動部分 |
2,020 |
- |
||||||
應付票據的流動部分，淨額 |
188,599 |
148,517 |
||||||
衍生負債 |
- |
|
||||||
總流動負債 |
725,867 |
814,448 |
||||||
經營租賃負債，淨值超過流動資產 |
106,114 |
164,295 |
||||||
金融租賃負債，減去流動部分 |
8,126 |
|||||||
應付款項-淨額 |
- |
228,871 |
||||||
負債合計 |
840,107 |
1,207,614 |
||||||
股東權益(赤字) |
||||||||
優先股，面值$0.001，授權10,000,000股；截至2024年9月30日和2023年12月31日，均未發行和流通。 |
- |
- |
||||||
普通股，面值$0.001，授權100,000,000股；截至2024年9月30日和2023年12月31日，分別發行和流通5,977,476股和4,617,798股。 |
5,977 |
4,618 |
||||||
追加實收資本 |
10,252,258 |
4,045,024 |
||||||
累積赤字 |
(6,774,180) | (4,158,054) | ||||||
股東權益合計（虧損） |
3,484,055 |
(108,412) | ||||||
總負債和股東權益（赤字） |
$ |
4,324,162 |
$ |
1,099,202 |
||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
KINDLY MD, INC.
捷凱收購公司二期有限公司
(未經審計)
For the Three Months Ended |
For the Nine Months Ended |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenues |
$ |
647,867 |
$ |
869,268 |
$ |
2,115,953 |
$ |
3,009,151 |
||||||||
Operating Expenses |
||||||||||||||||
Cost of revenues |
7,790 |
20,224 |
77,481 |
128,356 |
||||||||||||
Salaries and wages |
1,138,561 |
995,078 |
2,973,420 |
3,037,938 |
||||||||||||
General and administrative |
525,758 |
339,559 |
1,312,980 |
1,083,278 |
||||||||||||
Depreciation |
25,576 |
26,004 |
76,210 |
77,670 |
||||||||||||
Total Operating Expenses |
1,697,685 |
1,380,865 |
4,440,091 |
4,327,242 |
||||||||||||
LOSS FROM OPERATIONS |
(1,049,818) | (511,597) | (2,324,138) | (1,318,091) | ||||||||||||
Other Income (Expenses) |
||||||||||||||||
Other income |
45,330 |
9,001 |
71,198 |
46,302 |
||||||||||||
Interest expense |
(9,659) | (12,550) | (385,348) | (20,744) | ||||||||||||
Loss on extinguishment of debt |
- |
- |
(38,889) | - |
||||||||||||
Gain on change in fair value of derivative liability |
- |
- |
61,051 |
- |
||||||||||||
Total Other Income (Expenses) |
35,671 |
(3,549) | (291,988) | 25,558 |
||||||||||||
NET LOSS BEFORE INCOME TAXES |
(1,014,147) | (515,146) | (2,616,126) | (1,292,533) | ||||||||||||
INCOME TAX EXPENSE |
- |
- |
- |
- |
||||||||||||
NET LOSS |
$ |
(1,014,147) | $ |
(515,146) | $ |
(2,616,126) | $ |
(1,292,533) | ||||||||
LOSS PER COMMON SHARE - BASIC AND DILUTED |
$ |
(0.17) | $ |
(0.11) | $ |
(0.50) | $ |
(0.29) | ||||||||
WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED |
5,944,590 |
4,521,242 |
5,193,533 |
4,445,714 |
||||||||||||
截至三個月結束 |
截至九月三十日的九個月 |
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
收入 |
$ |
647,867 |
$ |
869,268 |
$ |
2,115,953 |
$ |
3,009,151 |
||||||||
運營費用 |
||||||||||||||||
收入成本 |
7,790 |
20,224 |
77,481 |
128,356 |
||||||||||||
工資薪金 |
1,138,561 |
995,078 |
2,973,420 |
3,037,938 |
||||||||||||
一般和行政 |
525,758 |
339,559 |
1,312,980 |
1,083,278 |
||||||||||||
折舊費 |
25,576 |
26,004 |
76,210 |
77,670 |
||||||||||||
總營業費用 |
1,697,685 |
1,380,865 |
4,440,091 |
4,327,242 |
||||||||||||
營業虧損 |
(1,049,818) | (511,597) | (2,324,138) | (1,318,091) | ||||||||||||
其他收入（支出） |
||||||||||||||||
其他收入 |
45,330 |
9,001 |
71,198 |
46,302 |
||||||||||||
利息支出 |
(9,659) | (12,550) | (385,348) | (20,744) | ||||||||||||
債務攤銷損失 |
- |
- |
(38,889) | - |
||||||||||||
衍生負債公允價值變動損益收益 |
- |
- |
61,051 |
- |
||||||||||||
其他收入（支出）總額 |
35,671 |
(3,549) | (291,988) | 25,558 |
||||||||||||
稅前淨虧損 |
(1,014,147) | (515,146) | (2,616,126) | (1,292,533) | ||||||||||||
所得稅費用 |
- |
- |
- |
- |
||||||||||||
淨損失 |
$ |
(1,014,147) | $ |
(515,146) | $ |
(2,616,126) | $ |
(1,292,533) | ||||||||
每股普通股損失-基本和稀釋 |
$ |
（0.17） | $ |
(0.11) | $ |
(0.50) | $ |
(0.29) | ||||||||
基本和稀釋後的加權平均股本數 |
5,944,590 |
4,521,242 |
5,193,533 |
4,445,714 |
||||||||||||
KINDLY MD, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
KINDLY MD, INC.
精簡現金流量表
(未經審計)
For the Nine Months Ended |
||||||||
2024 |
2023 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ |
(2,616,126) | $ |
(1,292,533) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
Stock-based compensation |
132,994 |
719,169 |
||||||
Depreciation expense |
76,210 |
77,670 |
||||||
Loss on extinguishment of debt |
38,889 |
- |
||||||
Gain on change in fair value of derivative liability |
(61,051) | - |
||||||
Amortization of debt discounts |
367,046 |
1,912 |
||||||
Amortization of right-of-use assets |
75,226 |
52,415 |
||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
(17,322) | 4,161 |
||||||
Inventories |
60,452 |
(47,131) | ||||||
Prepaid expenses and other current assets |
(250,091) | 33,398 |
||||||
Security deposits |
- |
3,229 |
||||||
Accounts payable and accrued expenses |
101,706 |
262,667 |
||||||
Customer deposits |
(675) | (2,050) | ||||||
Operating lease liabilities |
(79,619) | (53,713) | ||||||
Net cash used in operating activities |
(2,172,361) | (240,806) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Purchases of property and equipment |
(13,291) | (14,420) | ||||||
Net cash used in investing activities |
(13,291) | (14,420) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Net proceeds from issuance of notes payable |
45,000 |
- |
||||||
Net proceeds from issuance of related party note payable |
- |
250,373 |
||||||
Net proceeds from issuance of common shares and warrants in connection with a public offering |
5,860,650 |
- |
||||||
Repayments of related party note payable |
- |
(30,820) | ||||||
Repayments of notes payable |
(601,724) | - |
||||||
Repayments of finance lease liabilities |
(830) | - |
||||||
Net cash provided by financing activities |
5,303,096 |
219,553 |
||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
3,117,444 |
(35,673) | ||||||
CASH AND CASH EQUIVALENTS |
||||||||
Beginning of the period |
525,500 |
186,918 |
||||||
End of the period |
$ |
3,642,944 |
$ |
151,245 |
||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
||||||||
Cash paid for interest |
$ |
19,177 |
$ |
16,133 |
||||
Cash paid for income taxes |
$ |
- |
$ |
- |
||||
NON-CASH INVESTING AND FINANCING ACTIVITIES |
||||||||
Debt discounts on notes payable |
$ |
10,556 |
$ |
- |
||||
Debt discount on related party note payable |
$ |
- |
$ |
16,627 |
||||
Fair value of derivative liability recognized upon issuance of notes payable |
$ |
38,000 |
$ |
- |
||||
Extinguishment of derivative liability upon settlement of notes payable |
$ |
214,949 |
$ |
- |
||||
Finance purchases of property and equipment |
$ |
10,976 |
$ |
- |
||||
Operating lease right-of-use asset and liability measurement |
$ |
27,724 |
$ |
- |
||||
截至九月三十日的九個月 |
||||||||
2024 |
2023 |
|||||||
經營活動產生的現金流量 |
||||||||
淨虧損 |
$ |
(2,616,126) | $ |
(1,292,533) | ||||
調整爲淨損失到經營活動現金流量淨使用： |
||||||||
基於股票的補償 |
132,994 |
719,169 |
||||||
折舊費用 |
76,210 |
77,670 |
||||||
債務攤銷損失 |
38,889 |
- |
||||||
衍生負債公允價值變動損益收益 |
(61,051) | - |
||||||
債務貼現攤銷 |
367,046 |
1,912 |
||||||
攤銷租賃權資產 |
75,226 |
52,415 |
||||||
運營資產和負債的變化： |
||||||||
應收賬款 |
(17,322) | 4,161 |
||||||
存貨 |
60,452 |
(47,131) | ||||||
預付費用及其他流動資產 |
(250,091) | 33,398 |
||||||
按金 |
- |
3,229 |
||||||
應付賬款和應計費用 |
101,706 |
262,667 |
||||||
客戶存款 |
(675) | (2,050) | ||||||
營運租賃負債 |
(79,619) | (53,713) | ||||||
用於經營活動的淨現金 |
(2,172,361) | (240,806) | ||||||
投資活動產生的現金流量 |
||||||||
購買物業和設備 |
(13,291) | (14,420) | ||||||
投資活動中使用的淨現金 |
(13,291) | (14,420) | ||||||
籌資活動產生的現金流量 |
||||||||
發行應付票據的淨收益 |
45,000 |
- |
||||||
與相關方債務票據發行有關的淨收入 |
- |
250,373 |
||||||
與公開發行相關的普通股和認股權證淨收入 |
5,860,650 |
- |
||||||
相關方債務票據的償還 |
- |
(30,820) | ||||||
還款應付票據 |
(601,724) | - |
||||||
償還融資租賃負債 |
(830) | - |
||||||
融資活動提供的淨現金 |
5,303,096 |
219,553 |
||||||
現金及現金等價物的淨變動 |
3,117,444 |
(35,673) | ||||||
現金及現金等價物 |
||||||||
期初 |
525,500 |
186,918 |
||||||
期末 |
$ |
3,642,944 |
$ |
151,245 |
||||
現金流量補充資料 |
||||||||
支付的利息現金 |
$ |
19,177 |
$ |
16,133 |
||||
支付的所得稅費用 |
$ |
- |
$ |
- |
||||
非現金投融資活動 |
||||||||
應付票據的債務折扣 |
$ |
10,556 |
$ |
- |
||||
關聯方應付票據的債務折讓 |
$ |
- |
$ |
16,627 |
||||
發行應付票據時確認的衍生負債的公允價值 |
$ |
38,000 |
$ |
- |
||||
在結算應付票據時熄滅衍生負債 |
$ |
214,949 |
$ |
- |
||||
爲財務購買資產和設備 |
$ |
10,976 |
$ |
- |
||||
經營租賃權利資產和負債的計量 |
$ |
27,724 |
$ |
- |
||||
Contact Information
Valter Pinto
Managing Director, KCSA
kindlymd@kcsa.com
(212) 896-1254
聯繫信息
Valter Pinto
KCSA管理董事
kindlymd@kcsa.com
(212) 896-1254
SOURCE: KindlyMD, Inc.
來源：KindlyMD，Inc。
